Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

225.29 -0.26 (-0.12%)
Streaming Delayed Price Updated: 9:31 AM EDT, May 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
News headline image
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday? ↗
FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple chronic inflammatory diseases. 
Via Benzinga
News headline image
Donald Trump Vows To 'Call' Up CEOs Who Make Business Moves That Displease Him, Explains Why He Phoned Jeff Bezos To Scrap Amazon's Tariff Disclosure ↗
Trump claims he might personally phone CEOs for business moves he dislikes, using this tactic on Amazon's Bezos over tariff disclosures. 
Via Benzinga
Topics Government World Trade
News headline image
Analyzing JOHNSON & JOHNSON (NYSE:JNJ)'s Dividend Potential. ↗
Why JOHNSON & JOHNSON (NYSE:JNJ) provides a good dividend, while having solid fundamentals. 
Via Chartmill
News headline image
Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Now ↗
Via The Motley Fool
Topics Government Stocks World Trade
News headline image
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? ↗
Via The Motley Fool
Topics Earnings Economy Government
News headline image
Johnson & Johnson - Elliott Wave Technical Analysis ↗
We are tracking a potential major bottom forming in Primary wave 2. A clear five-wave move into wave {i} suggests the early stages of an upside trend resumption. 
Via Talk Markets
News headline image
40-Year-Old Making $4K a Month in Dividends Reveals His Top 8 Stocks — 'We Don't Wear Fancy Clothes or Spend Money on Impressing Others' ↗
 
Via Benzinga
News headline image
8 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again? ↗
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year? 
Via Investor's Business Daily
Topics Animal Testing Economy Government
News headline image
Nvidia, Johnson & Johnson, Hyundai, Toyota, SoftBank CEOs To Join Trump At White House As He Touts Investment Surge In First 100 Days: Report ↗
Trump to highlight investments from top companies, including Nvidia, J&J, and Toyota, in 'Investing in America' event to mark first 100 days in office. 
Via Benzinga
Topics Government
News headline image
Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference
From Johnson & Johnson
Via Business Wire
News headline image
Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications ↗
A lawsuit claims Eli Lilly, Johnson & Johnson, and Kaiser Permanente failed to warn consumers about breast cancer risks linked to their antipsychotic drugs Risperdal and Zyprexa. 
Via Benzinga
Topics Lawsuit
News headline image
AbbVie Immunology Portfolio Poised For Growth Through Humira Erosion: Analyst ↗
Analysts raise AbbVie price targets after strong Q1 results, driven by Skyrizi, Rinvoq growth and strategic moves in Parkinson's disease treatments. 
Via Benzinga
News headline image
CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug ↗
The companies are working on treatments for a form of bladder cancer. 
Via Investor's Business Daily
News headline image
3 Industry Behemoths Are Rewarding Investors With Dividend Bumps
See these three stocks that are among the most important in their industries, which have announced sizable increases in their dividends. 
Via MarketBeat
Topics World Trade
News headline image
3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
See these three top-10 stocks in the pharmaceutical industry that are pledging investment in the United States totalling over $100 billion. 
Via MarketBeat
Topics Artificial Intelligence Economy Government
News headline image
These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys? ↗
Via The Motley Fool
Topics Economy Government Lawsuit
News headline image
3 Dividend Kings That Have Raised Their Payouts in 2025 ↗
Via The Motley Fool
Topics Economy
News headline image
In the Wake of the Trump Tariff Crash: 2 Unparalleled Dividend Stocks to Buy at a Discount Right Now ↗
Short-term tariff uncertainty marks the perfect opportunity for long-term investors to snag some amazing deals. 
Via The Motley Fool
Topics Economy Government Stocks
News headline image
Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings
Global pharmaceutical company Merck (NYSE:MRK) will be reporting results tomorrow before market hours. Here’s what to expect. 
Via StockStory
News headline image
Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results tomorrow morning. Here’s what investors should know. 
Via StockStory
News headline image
Trump Administration Considers Lowering US Drug Prices To International Levels: Report ↗
The Trump Administration is reportedly mulling over a policy to match U.S. drug prices with those in other developed nations. 
Via Benzinga
Topics Government
News headline image
JNJ Q1 Earnings: Pipeline Progress and MedTech Execution Drive Guidance Above Expectations
Multinational healthcare company Johnson & Johnson (NYSE:JNJ) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.4% year on year to $21.89 billion. The company’s full-year revenue... 
Via StockStory
Topics Earnings World Trade
News headline image
Why Johnson & Johnson, Chevron, And Flowers Foods Are Winners For Passive Income ↗
 
Via Benzinga
News headline image
Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs ↗
Roche to invest $50 billion in U.S. over five years, adding 12,000+ jobs and expanding manufacturing, R&D, and export capacity across eight states. 
Via Benzinga
News headline image
9 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings?
Johnson & Johnson has been treading water for the past six months, recording a small loss of 3.8% while holding steady at $157.30. However, the stock is beating the S&P 500’s 11% decline during that... 
Via StockStory
Topics Stocks
News headline image
2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government ↗
Via The Motley Fool
Topics Artificial Intelligence Economy Government
News headline image
From $50 A Month To $1M Portfolio — Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline ↗
 
Via Benzinga
News headline image
Stocks That Weathered Past Recessions: Expert Shares Picks That Withstood Every Downturn ↗
Stock market expert Jon Erlichman recently shared a review of stock returns during the last six U.S. recessions, highlighting those that have performed well in difficult times. 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.